LPL and systemic sclerosis: These antibodies were closely associated to the elevated levels of triglycerides in SLE and SSc and a putative functional role of anti-LPL in these diseases came from the observation that IgG fraction from SSc patient anti-LPL positive and with elevated serum triglyceride levels was able to significantly inhibit in vitro the enzyme activity [3].